Literature DB >> 3202650

Oral vancomycin in prevention of necrotising enterocolitis.

P C Ng1, P R Dear, D F Thomas.   

Abstract

Eighty four very low birthweight babies (considered high risk for developing necrotising enterocolitis) were given vancomycin orally for 48 hours before introduction of oral feeds; one developed necrotising enterocolitis. One hundred and twenty very low birthweight babies (not considered such high risk) were fed without first receiving vancomycin; 17 developed necrotising enterocolitis. Although this was not a randomised control trial, results indicate a role for vancomycin in prophylaxis of necrotising enterocolitis.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3202650      PMCID: PMC1779178          DOI: 10.1136/adc.63.11.1390

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  5 in total

1.  Alterations in stool flora resulting from oral kanamycin prophylaxis of necrotizing enterocolitis.

Authors:  R Boyle; J S Nelson; B S Stonestreet; G Peter; W Oh
Journal:  J Pediatr       Date:  1978-11       Impact factor: 4.406

2.  A prospective controlled trial of oral kanamycin in the prevention of neonatal necrotizing enterocolitis.

Authors:  E A Egan; G Mantilla; R M Nelson; D V Eitzman
Journal:  J Pediatr       Date:  1976-09       Impact factor: 4.406

3.  An outbreak of Clostridium difficile necrotizing enterocolitis: a case for oral vancomycin therapy?

Authors:  V K Han; H Sayed; G W Chance; D G Brabyn; W A Shaheed
Journal:  Pediatrics       Date:  1983-06       Impact factor: 7.124

4.  Oral gentamicin therapy in the prevention of neonatal necrotizing enterocolitis. A controlled double-blind trial.

Authors:  L J Grylack; J W Scanlon
Journal:  Am J Dis Child       Date:  1978-12

5.  Necrotising enterocolitis in the very low birthweight infant: expressed breast milk feeding compared with parenteral feeding.

Authors:  F Eyal; E Sagi; I Arad; A Avital
Journal:  Arch Dis Child       Date:  1982-04       Impact factor: 3.791

  5 in total
  2 in total

1.  Double blind, randomised, placebo controlled study of oral vancomycin in prevention of necrotising enterocolitis in preterm, very low birthweight infants.

Authors:  Y K Siu; P C Ng; S C Fung; C H Lee; M Y Wong; T F Fok; K W So; K L Cheung; W Wong; A F Cheng
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1998-09       Impact factor: 5.747

Review 2.  Gastrointestinal host defense and necrotizing enterocolitis.

Authors:  J N Udall
Journal:  J Pediatr       Date:  1990-07       Impact factor: 4.406

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.